Skip to main content
Acquis Logo
Pratna Ramachandran image

Pratna Ramachandran

Engagement Manager

Industry expertise

  • Life Sciences

View Full Team

Life is what you make it. No matter what, you’re going to mess up sometimes, it’s a universal truth. But the good part is you get to decide how you mess it up.
- Marilyn Monroe

Pratna has been a strategic advisor for several mid-sized and top 20 pharmaceutical companies and has deep expertise across the pharmaceutical value chain, specializing in early commercialization to loss of exclusivity.

Pratna has deep expertise leading strategy planning, management, and execution initiatives across the pharmaceutical value chain and lifecycle. Her primary focus is on project management, brand strategy, and product launch and has worked on several engagements with the Commercial Operations and Medical Affairs functions.

Pratna has been a strategic advisor for several top 20 pharmaceutical companies around the globe and has supported global product launches across the United States, Europe, and Japan. Her clients in Life Sciences include small to large pharmaceutical, diagnostic equipment, biotechnology, medical device, and digital medicine manufacturers.​ Prior to joining Acquis Consulting Group, Pratna earned her degree at Illinois Wesleyan University where she studied Biology and Sociology.

Previous Team Member

Next Team Member

Insights by Pratna Ramachandran

  • A colorful display of various national flags waving on flagpoles against a night sky, representing international unity and diversity.
    Article

    Most Favored Nation Will Change More Than Pricing

    The May 2025 Most Favored Nation (MFN) executive order aims to align US drug pricing with the lowest prices paid by other developed nations. On the surface, it is a pricing policy. In practice, it is something more consequential.

    Read More

  • Preparing for the Next Decentralized Clinical Trial Quantum Leap  image
    Article

    Preparing for the Next Decentralized Clinical Trial Quantum Leap 

    The clinical trial landscape is transforming and pivoting away from its reliance on data collection within the confines of traditional research facilities.

    Read More

  • ­­­Quantitative Operating Model Design for Life Sciences Organizations in the Era of AI image
    Article

    ­­­Quantitative Operating Model Design for Life Sciences Organizations in the Era of AI

    In recent years, the Life Sciences industry has witnessed a significant transformation due to the convergence of digital innovation and artificial intelligence (AI). The Life Science companies that are best at deploying AI and machine learning to expedite drug discovery, personalize medicine, and make patient-centric decisions will come out significantly ahead over those that do not.

    Read More

Related Team Members